ESMO 2022 Conference Coverage
ESMO 2022 on the Additional Practice-Informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study: Adagrasib in KRASG12Cm NSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Jun Zhang
By
ESMO 2022 Conference Coverage
FEATURING
Jun Zhang
This video was recorded prior to the FDA granting approval to Adagrasib (Krazati) on December ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
